Voya Investment Management LLC Travere Therapeutics, Inc. Transaction History

Voya Investment Management LLC

  • $78.9 Billion
  • Q4 2024

A detailed history of Voya Investment Management LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 199,672 shares of TVTX stock, worth $4.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199,672
Previous 222,470 10.25%
Holding current value
$4.27 Million
Previous $3.11 Million 11.76%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$13.65 - $19.85 $311,192 - $452,540
-22,798 Reduced 10.25%
199,672 $3.48 Million
Q3 2024

Feb 07, 2025
BUY
$7.89 - $15.21 $1.56 Million - $3 Million
197,528 Added 791.95%
222,470 $3.11 Million
Q3 2024

Nov 14, 2024
BUY
$7.89 - $15.21 $1.56 Million - $3 Million
197,528 Added 791.95%
222,470 $3.11 Million
Q2 2024

Feb 07, 2025
SELL
$5.26 - $8.28 $961,738 - $1.51 Million
-182,840 Reduced 88.0%
24,942 $205,000
Q2 2024

Dec 03, 2024
SELL
$5.26 - $8.28 $1.04 Million - $1.64 Million
-197,528 Reduced 88.79%
24,942 $205,000
Q2 2024

Aug 14, 2024
SELL
$5.26 - $8.28 $961,738 - $1.51 Million
-182,840 Reduced 88.0%
24,942 $205,000
Q1 2024

Feb 07, 2025
SELL
$7.18 - $9.82 $105,459 - $144,236
-14,688 Reduced 6.6%
207,782 $1.6 Million
Q1 2024

Dec 06, 2024
SELL
$7.18 - $9.82 $105,459 - $144,236
-14,688 Reduced 6.6%
207,782 $1.6 Million
Q1 2024

May 15, 2024
BUY
$7.18 - $9.82 $1.28 Million - $1.75 Million
178,402 Added 607.22%
207,782 $1.6 Million
Q4 2023

Feb 07, 2025
SELL
$5.44 - $9.5 $101,156 - $176,652
-18,595 Reduced 38.76%
29,380 $264,000
Q4 2023

Feb 14, 2024
SELL
$5.44 - $9.5 $101,156 - $176,652
-18,595 Reduced 38.76%
29,380 $264,000
Q3 2023

Feb 07, 2025
BUY
$7.64 - $17.25 $4,347 - $9,815
569 Added 1.2%
47,975 $428,000
Q3 2023

Nov 14, 2023
BUY
$7.64 - $17.25 $4,347 - $9,815
569 Added 1.2%
47,975 $428,000
Q2 2023

Feb 07, 2025
BUY
$15.3 - $22.61 $82,451 - $121,845
5,389 Added 12.83%
47,406 $728,000
Q2 2023

Aug 14, 2023
BUY
$15.3 - $22.61 $82,451 - $121,845
5,389 Added 12.83%
47,406 $728,000
Q1 2023

Feb 07, 2025
SELL
$17.82 - $22.89 $3.22 Million - $4.13 Million
-180,453 Reduced 81.11%
42,017 $944,000
Q4 2022

Feb 07, 2025
SELL
$18.47 - $26.14 $24,565 - $34,766
-1,330 Reduced 3.07%
42,017 $883,000
Q4 2022

Feb 14, 2023
SELL
$18.47 - $26.14 $24,565 - $34,766
-1,330 Reduced 3.07%
42,017 $883,000
Q3 2022

Feb 07, 2025
SELL
$22.91 - $28.63 $4.1 Million - $5.13 Million
-179,123 Reduced 80.52%
43,347 $1.07 Million
Q3 2022

Mar 03, 2023
BUY
$22.91 - $28.63 $30,470 - $38,077
1,330 Added 3.17%
43,347 $1.07 Million
Q3 2022

Nov 14, 2022
SELL
$22.91 - $28.63 $1.05 Million - $1.31 Million
-45,635 Reduced 51.29%
43,347 $1.07 Million
Q2 2022

Aug 15, 2022
BUY
$20.94 - $30.01 $1.37 Million - $1.97 Million
65,560 Added 279.91%
88,982 $2.16 Million
Q1 2022

May 16, 2022
BUY
$23.61 - $30.6 $9,656 - $12,515
409 Added 1.78%
23,422 $604,000
Q4 2021

Feb 14, 2022
SELL
$24.34 - $31.17 $7,082 - $9,070
-291 Reduced 1.25%
23,013 $715,000
Q3 2021

Nov 15, 2021
SELL
$12.98 - $25.03 $259 - $500
-20 Reduced 0.09%
23,304 $565,000
Q2 2021

Aug 16, 2021
BUY
$14.11 - $26.4 $4,472 - $8,368
317 Added 1.38%
23,324 $341,000
Q1 2021

May 17, 2021
BUY
$23.37 - $31.77 $22,832 - $31,039
977 Added 4.43%
23,007 $574,000
Q4 2020

Feb 16, 2021
BUY
$19.17 - $27.87 $422,315 - $613,976
22,030 New
22,030 $600,000

Others Institutions Holding TVTX

# of Institutions
219
Shares Held
92.7M
Call Options Held
1.2M
Put Options Held
778K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.37B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email